News

Fierce 15 nominations are open! We're searching for the most innovative, resourceful and visionary biotechs leading the way ...
So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...
Here are the key moments to know from its history. Biotech was born in the Bay Area 50 years ago. Here's what lies ahead This startup is on a mission to fight lung cancer early on This startup is ...
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Questex's Fierce Biotech today announces the finalists of the second annual Fierce CRO Awards. The Fierce CRO Awards celebrate exceptional achievements and ...
Oncolytics Biotech Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.09. Operator: Good afternoon, and welcome to Oncolytics Biotech First Quarter Conference Call.
Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
This summary of the amended credit agreement is qualified in its entirety by reference to the full agreement filed as an exhibit to the Company's Form 6-K filed with the ... to statements related to ...
Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still have a desire to back companies working on RIPK1 inhibitors despite setbacks for GSK in ...
Pfizer’s plans to duck out of central nervous system R&D have come to fruition, with the creation of spinout biotech Cerevel Therapeutics. The new Boston area company is taking over a sizeable ...
A trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 19, 2025. REUTERS/Jeenah Moon/File Photo Morgan Stanley turned bullish on most major U.S. assets ...